Hypoxia-inducible factors: a central link between inflammation and cancer
Open accessAbstract
The tumor immune response is in a dynamic balance between antitumor mechanisms, which serve to decrease cancer growth, and the protumor inflammatory response, which increases immune tolerance, cell survival, and proliferation. Hypoxia and expression of HIF-1α and HIF-2α are characteristic features of all solid tumors. HIF signaling serves as a major adaptive mechanism in tumor growth in a hypoxic microenvironment. HIFs represent a critical signaling node in the switch to protumorigenic inflammatory responses through recruitment of protumor immune cells and altered immune cell effector functions to suppress antitumor immune responses and promote tumor growth through direct growth-promoting cytokine production, angiogenesis, and ROS production. Modulating HIF function will be an important mechanism to dampen the tumor-promoting inflammatory response and inhibit cancer growth.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HIFs play critical roles in cancer progression by activating transcription of genes encoding proteins involved in angiogenesis, glucose metabolism, invasion/metastasis, stem cell specification, protumoral inflammatory responses, and tumor immune evasion.
“Hypoxia-inducible factors (HIFs) play critical roles in cancer progression by activating the transcription of a large battery of genes encoding proteins that play key roles in angiogenesis, glucose metabolism, invasion/metastasis, stem cell specification, protumoral inflammatory responses, and tumor immune evasion (18, 23–27).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [26]
The Introduction describes HIFs as transcription factors and critical drivers of cancer that regulate metabolism, angiogenesis, and invasion/metastasis. The Conclusion and “Hypoxic regulation of tumor immune cell function” also connect HIF signaling to protumor inflammation and suppression of antitumor immunity. Our copy does not support the specific addition of stem cell specification to this list. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThis chemokine-driven recruitment can suppress anti-tumor immunity and induce chronic inflammation, which promotes cancer progression by facilitating tumor cell proliferation, survival, angiogenesis, and metastasis.
“This can result in suppression of the anti-tumor immune response and induce chronic inflammation, which contributes to cancer progression by facilitating tumor cell proliferation, cell survival, angiogenesis and metastasis [68].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · see citing works
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · see citing works
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · see citing works
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202 · see citing works
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · see citing works
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820 · see citing works
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · see citing works
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516 · see citing works
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · see citing works
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,834 · see citing works
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · see citing works
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · see citing works
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148 · see citing works
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,025 · see citing works
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · see citing works
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L. E., Worthen, G. S., & Albelda, S. Μ. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,382 · see citing works
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,096 · see citing works
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · see citing works
Vincent, A., Herman, J. M., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,612 · see citing works
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502 · see citing works
Sato, E., Olson, S. H., Ahn, J., Bundy, B. N., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C. B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,375 · see citing works
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166 · see citing works
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 1× · see citing works
“Expression profiles associated with antitumor T cell cytokines (IFN-γ) and effector molecules (granulysin and granzyme B) are also independent prognosticators of decreased early metastasis in colon cancer (37).”
BackgroundCancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3258 · Cited by 2,060 · see citing works
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · see citing works
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805 · see citing works
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., et al. (2015) · Nature · doi:10.1038/nature14282 · Cited by 1,703 · see citing works
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · cited 1× · see citing works
“Although HIF-1α and HIF-2α have several overlapping functions, distinct target genes and functions for HIF-1α and HIF-2α are well characterized (17) and highlighted in several tumor models (18).”
BackgroundNF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614 · see citing works
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595 · see citing works
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514 · see citing works
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386 · see citing works
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376 · see citing works
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327 · see citing works
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312 · see citing works
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276 · see citing works
Movahedi, K., Laoui, D., Gysemans, C. A., Baeten, M., Stangé, G. M., den Bossche, J. V., Mack, M., PIPELEERS, D. G., Veld, P. I. '., BAETSELIER, P. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,229 · see citing works
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195 · see citing works
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Писарев, В. М., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J. P., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,176 · see citing works
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173 · see citing works
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136 · cited 1× · see citing works
“It is now evident that epithelial surfaces play an active role in innate immunity and shape the underlying immune environment and inflammatory response (38, 39).”
BackgroundDu, R., Lu, K. V., Petritsch, C. K., Liu, P., Ganß, R., Passegue, E. A., Song, H., VandenBerg, S. R., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,131 · see citing works
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution
McGranahan, N., & Swanton, C. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.001 · Cited by 1,077 · see citing works
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
Lin, E. Y., Li, J.-F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X.-N., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1278 · Cited by 1,074 · see citing works
Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties
Schwitalla, S., Fingerle, A. A., Cammareri, P., Nebelsiek, T., Göktuna, S. İ., Ziegler, P. K., Canli, Ö., Heijmans, J., Huels, D. J., Moreaux, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.12.012 · Cited by 1,057 · see citing works
Macrophages in Tumor Microenvironments and the Progression of Tumors
Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/948098 · Cited by 1,003 · see citing works
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Sato, K., Ozaki, K., Oh, I., Meguro, A., Hatanaka, K., Nagai, T., Muroi, K., & Ozawa, K. (2006) · Blood · doi:10.1182/blood-2006-02-002246 · Cited by 952 · see citing works
Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940 · see citing works
Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity
Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., Sobolewski, A., Condliffe, A. M., Cowburn, A. S., Johnson, N., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040624 · Cited by 891 · see citing works
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar‐Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 854 · see citing works
Regulatory T cells: how do they suppress immune responses?
Sakaguchi, S., Wing, K., Onishi, Y., Martín, P. P., & Yamaguchi, T. (2009) · International Immunology · doi:10.1093/intimm/dxp095 · Cited by 850 · see citing works
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P. J., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 846 · see citing works
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
Popivanova, B. K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., & Mukaida, N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32453 · Cited by 845 · see citing works
Boire, A. A., Covic, L., Agarwal, A., Jacques, S. L., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 841 · see citing works
Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841 · see citing works
HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity
Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781 · see citing works
Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs
Wiesener, M. S., Jürgensen, J. S., Rosenberger, C., Scholze, C. K., Hörstrup, J. H., Warnecke, C., Mandriota, S. J., Bechmann, I., Frei, U. A., Pugh, C. W., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0445fje · Cited by 741 · see citing works
Gocheva, V., Wang, H., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T. A., & Joyce, J. A. (2010) · Genes & Development · doi:10.1101/gad.1874010 · Cited by 739 · see citing works
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
Mabjeesh, N. J., Escuin, D., LaVallee, T. M., Pribluda, V. S., Swartz, G. M., Johnson, M. S., Willard, M. T., Zhong, H., Simons, J. W., & Giannakakou, P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00077-1 · Cited by 730 · see citing works
Rodrı́guez, P. C., & Ochoa, A. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00608.x · Cited by 722 · see citing works
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 692 · see citing works
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
Knutson, K. L., & Disis, M. L. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0653-2 · Cited by 689 · see citing works
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 676 · see citing works
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen
Doedens, A. L., Phan, A. T., Stradner, M. H., Fujimoto, J. K., Nguyen, J. V., Yang, E., Johnson, R. S., & Goldrath, A. W. (2013) · Nature Immunology · doi:10.1038/ni.2714 · Cited by 660 · see citing works
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652 · see citing works
Stromal contribution to the colorectal cancer transcriptome
Isella, C., Terrasi, A., Bellomo, S. E., Petti, C., Galatola, G., Muratore, A., Mellano, A., Senetta, R., Cassenti, A., Sonetto, C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3224 · Cited by 640 · see citing works
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A. N., & Kzhyshkowska, J. G. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 631 · see citing works
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624 · see citing works
Takeda, N., O'Dea, E. L., Doedens, A. L., Kim, J., Weidemann, A., Stockmann, C., Asagiri, M., Simon, M. C., Hoffmann, A., & Johnson, R. S. (2010) · Genes & Development · doi:10.1101/gad.1881410 · Cited by 621 · see citing works
Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S., Ginderachter, J. V. V., Tamagnone, L., & Mazzone, M. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.007 · Cited by 601 · see citing works
Tumor associated macrophages and neutrophils in cancer
Galdiero, M. R., Bonavita, E., Barajon, I., Garlanda, C., Mantovani, A., & Jaillon, S. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.003 · Cited by 597 · see citing works
Gu, Y.-Z., Moran, S. M., Hogenesch, J. B., Wartman, L. D., & Bradfield, C. A. (1998) · Europe PMC (PubMed Central) · Cited by 577 · see citing works
Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease
Munkholm, P. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.18.s2.2.x · Cited by 570 · see citing works
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560 · see citing works
TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions
Martínez‐Reyes, I., Diebold, L. P., Kong, H., Schieber, M., Huang, H., Hensley, C. T., Mehta, M., Wang, T., Santos, J. H., Woychik, R. P., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.002 · Cited by 512 · see citing works
MET is required for the recruitment of anti-tumoural neutrophils
Finisguerra, V., Conza, G. D., Matteo, M. D., Serneels, J., Costa, S., Thompson, A. A. R., Wauters, E., Walmsley, S. R., Prenen, H., Granot, Z., et al. (2015) · Nature · doi:10.1038/nature14407 · Cited by 494 · see citing works
Katoh, H., Wang, D., Daikoku, T., Sun, H., Dey, S. K., & DuBois, R. N. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.009 · Cited by 477 · see citing works
Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1
Hellwig‐Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., & JELKMANN, W. E. B. (1999) · Blood · doi:10.1182/blood.v94.5.1561.417a06_1561_1567 · Cited by 475 · see citing works
Campbell, E. L., Bruyninckx, W. J., Kelly, C. J., Glover, L. E., McNamee, E. N., Bowers, B., Bayless, A. J., Scully, M. M., Saeedi, B. J., Golden‐Mason, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.020 · Cited by 472 · see citing works
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461 · see citing works
Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK
Hagemann, T., Wilson, J. L., Kulbe, H., Li, N. F., Leinster, D. A., Charles, K. A., Klemm, F., Pukrop, T., Binder, C. R., & Balkwill, F. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1197 · Cited by 433 · see citing works
Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis
Kim, E. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9872 · Cited by 420 · see citing works
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Bonavita, E., Gentile, S., Rubino, M., Maina, V., Papait, R., Kunderfranco, P., Greco, C. M., Feruglio, F., Molgora, M., Laface, I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.004 · Cited by 417 · see citing works
Jantsch, J., Chakravortty, D., Turza, N., Prechtel, A. T., Buchholz, B., Gerlach, R. G., Volke, M., Gläsner, J., Warnecke, C., Wiesener, M. S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4697 · Cited by 414 · see citing works
Macrophage Responses to Hypoxia
Lewis, C., & Murdoch, C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62038-x · Cited by 413 · see citing works
In VivoExpression of mRNAs Encoding Hypoxia-Inducible Factor 1
Wiener, C. M., Booth, G., & Semenza, G. L. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1199 · Cited by 413 · see citing works
Laoui, D., Overmeire, E. V., Conza, G. D., Aldeni, C., Keirsse, J., Morias, Y., Movahedi, K., Houbracken, I., Schouppe, E., Elkrim, Y., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1196 · Cited by 410 · see citing works
The Hydroxylase Inhibitor Dimethyloxalylglycine Is Protective in a Murine Model of Colitis
Cummins, E. P., Seeballuck, F., Keely, S. J., Mangan, N. E., Callanan, J. J., Fallon, P. G., & Taylor, C. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.012 · Cited by 407 · see citing works
Chun, E., Lavoie, S., Michaud, M., Gallini, C. A., Kim, J., Soucy, G., Odze, R., Glickman, J. N., & Garrett, W. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.024 · Cited by 402 · cited 1× · see citing works
“Colon tumor cell secretion of the C-C family chemokine, CCL2, was essential for tumorigenesis through recruitment and activation of protumorigenic myeloid cells (40).”
BackgroundTNF signaling drives myeloid-derived suppressor cell accumulation
Zhao, X., Rong, L., Zhao, X., Li, X., Liu, X., Deng, J., Wu, H., Xu, X., Erben, U., Wu, P., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64115 · Cited by 380 · see citing works
Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition
Robinson, A., Keely, S., Karhausen, J., Gerich, M. E., Furuta, G. T., & Colgan, S. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.09.033 · Cited by 368 · see citing works
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Lu, T., Ramakrishnan, R., Altiok, S., Youn, J. I., Cheng, P., Celis, E., Писарев, В. М., Sherman, S., Sporn, M. B., & Gabrilovich, D. I. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45862 · Cited by 365 · see citing works
Sceneay, J., Chow, M. T., Chen, A., Halse, H. M., Wong, C. S. F., Andrews, D. M., Sloan, E. K., Parker, B. S., Bowtell, D. D. L., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3873 · Cited by 365 · see citing works
Structural integration in hypoxia-inducible factors
Wu, D., Potluri, N., Lu, J., Kim, Y., & Rastinejad, F. (2015) · Nature · doi:10.1038/nature14883 · Cited by 346 · see citing works
T helper 17 cells play a critical pathogenic role in lung cancer
Chang, S. H., Mirabolfathinejad, S. G., Katta, H., Cumpian, A. M., Gong, L., Caetano, M. S., Moghaddam, S. J., & Dong, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319051111 · Cited by 326 · see citing works
Allosteric inhibition of hypoxia inducible factor-2 with small molecules
Scheuermann, T. H., Li, Q., Ma, H.-W., Key, J., Zhang, L., Chen, R., Garcia, J. A., Naidoo, J., Longgood, J., Frantz, D. E., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1185 · Cited by 315 · see citing works
Artificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor
Scheuermann, T. H., Tomchick, D. R., Machius, M., Guo, Y., Bruick, R. K., & Gardner, K. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808092106 · Cited by 301 · see citing works
A non‐hypoxic, ROS‐sensitive pathway mediates TNF‐α‐dependent regulation of HIF‐1α
Haddad, J. J., & Land, S. C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02833-2 · Cited by 270 · see citing works
Klages, K., Mayer, C. T., Lahl, K., Loddenkemper, C., Teng, M. W. L., Ngiow, S. F., Smyth, M. J., Hamann, A., Huehn, J., & Sparwasser, T. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1736 · Cited by 267 · see citing works
Hypoxia controls CD4+CD25+ regulatory T‐cell homeostasis via hypoxia‐inducible factor‐1α
Ben‐Shoshan, J., Maysel-Auslender, S., Mor, A., Keren, G., & George, J. (2008) · European Journal of Immunology · doi:10.1002/eji.200838318 · Cited by 260 · see citing works
Whole-exome Sequencing analyses of Inflammatory Bowel Disease-associated Colorectal Cancers
Robles, A., Traverso, G., Zhang, M., Roberts, N. J., Khan, M. A., Joseph, C. G., Lauwers, G., Selaru, F., Popoli, M., Pittman, M., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.036 · Cited by 252 · see citing works
Natural and Induced T Regulatory Cells in Cancer
Adeegbe, D. O., & Nishikawa, H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00190 · Cited by 248 · see citing works
Tripathi, C., Tewari, B. N., Kanchan, R. K., Baghel, K. S., Nautiyal, N., Shrivastava, R., Kaur, H., Bhatt, M. L. B., & Bhadauria, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2110 · Cited by 223 · see citing works
Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., Berenfeld, L., Wenger, R. H., Ohta, A., & Sitkovsky, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.4962 · Cited by 208 · see citing works
Hif1α deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia
Lee, K., Spata, M., Bayne, L., Buza, E., Durham, A., Allman, D., Vonderheide, R., & Simon, M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0822 · Cited by 203 · see citing works
Leek, R., Talks, K., Pezzella, F., Turley, H., Campo, L., Brown, N. S., Bicknell, R., Taylor, M., Gatter, K. C., & Harris, A. L. (2002) · PubMed · Cited by 201 · see citing works
Zimmer, M., Ebert, B. L., Neil, C., Brenner, K., Papaioannou, I., Melas, A., Tolliday, N., Lamb, J., Pantopoulos, K., Golub, T., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.004 · Cited by 191 · see citing works
Hlatky, L., Tsionou, C., Hahnfeldt, P., & Coleman, C. N. (1994) · PubMed · Cited by 189 · see citing works
Divergent effects of hypoxia on dendritic cell functions
Mancino, A., Schioppa, T., Larghi, P., Pasqualini, F., Nebuloni, M., Chen, I., Sozzani, S., Austyn, J. M., Mantovani, A., & Sica, A. (2008) · Blood · doi:10.1182/blood-2008-02-142091 · Cited by 186 · see citing works
Palazón, A., Martínez‐Forero, I., Teijeira, Á., Morales‐Kastresana, A., Alfaro, C., Sanmamed, M. F., Perez‐Gracia, J. L., Peñuelas, I., Hervás‐Stubbs, S., Rouzaut, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0314 · Cited by 186 · see citing works
IL-17 Enhances Tumor Development in Carcinogen-Induced Skin Cancer
Wang, L., Yi, T., Zhang, W., Pardoll, D. M., & Yu, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0775 · Cited by 186 · see citing works
Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells
Blaisdell, A., Créquer-Grandhomme, A., Columbus, D., Daikoku, T., Mittal, K., Dey, S. K., & Erlebacher, A. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.005 · Cited by 176 · see citing works
“Of Mice and Men”: Arginine Metabolism in Macrophages
Thomas, A. C., & Mattila, J. T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00479 · Cited by 175 · see citing works
Xue, X., Ramakrishnan, S. K., Anderson, E. R., Taylor, M. J., Zimmermann, E. M., Spence, J. R., Huang, S., Greenson, J. K., & Shah, Y. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.010 · Cited by 171 · see citing works
Self-citationBurke, B., Tang, N., Corke, K. P., Tazzyman, D., Ameri, K., Wells, M. W., & Lewis, C. E. (2001) · The Journal of Pathology · doi:10.1002/path.1029 · Cited by 169 · see citing works
Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
Branco-Price, C., Zhang, N., Schnelle, M., Evans, C., Katschinski, D. M., Liao, D., Ellies, L., & Johnson, R. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.017 · Cited by 168 · see citing works
Rabinowitz, M. H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400386j · Cited by 165 · see citing works
HIF1A Reduces Acute Lung Injury by Optimizing Carbohydrate Metabolism in the Alveolar Epithelium
Eckle, T. D. L. G., Brodsky, K. S., Bonney, M., Packard, T. A., Han, J., Borchers, C. H., Mariani, T. J., Kominsky, D. J., Mittelbronn, M. G. A., & Eltzschig, H. K. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001665 · Cited by 165 · see citing works
Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression
Li, Q., Lao, X., Pan, Q., Ning, N., Yet, J., Xu, Y., Li, S., & Chang, A. E. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0207 · Cited by 158 · see citing works
The role of HIF in immunity and inflammation
Cummins, E. P., Keogh, C. E., Crean, D., & Taylor, C. T. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.004 · Cited by 153 · see citing works
Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish
Thompson, A. A. R., Elks, P. M., Marriott, H. M., Eamsamarng, S., Higgins, K. R., Lewis, A., Williams, L., Parmar, S., Shaw, G., McGrath, E. E., et al. (2013) · Blood · doi:10.1182/blood-2013-05-500207 · Cited by 150 · see citing works
Xue, X., Taylor, M. J., Anderson, E. R., Hao, C., Qu, A., Greenson, J. K., Zimmermann, E. M., Gonzalez, F. J., & Shah, Y. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3836 · Cited by 146 · see citing works
Self-citationNoman, M. Z., Janji, B., Hu, S., Wu, J. C., Martelli, F., Bronte, V., & Chouaı̈b, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0405 · Cited by 144 · see citing works
Helicobacter pylori in gastric carcinogenesis
Ahn, H. J., & Lee, D. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i12.455 · Cited by 135 · see citing works
Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α
Haddad, J. J., & Harb, H. L. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.11.009 · Cited by 134 · see citing works
HIF-2α deletion promotes Kras-driven lung tumor development
Mazumdar, J., Hickey, M. M., Pant, D. K., Durham, A. C., Sweet-Cordero, A., Vachani, A., Jacks, T., Chodosh, L. A., Kissil, J. L., Simon, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001296107 · Cited by 130 · see citing works
Efficient Treg depletion induces T‐cell infiltration and rejection of large tumors
Li, X., Kostareli, E., Suffner, J., Garbi, N., & Hämmerling, G. J. (2010) · European Journal of Immunology · doi:10.1002/eji.201041093 · Cited by 126 · see citing works
Deng, B., Zhu, J., Wang, Y., Liu, T., Ding, Y., Xiao, W., Lu, G., Bo, P., & Shen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063777 · Cited by 121 · see citing works
Siegert, I., Schödel, J., Nairz, M., Schatz, V., Dettmer, K., Dick, C., Kalucka, J., Franke, K., Ehrenschwender, M., Schley, G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.005 · Cited by 110 · cited 1× · see citing works
“LPS-induced NF-κB can also enhance HIF-1α protein stability by increasing intracellular ferritin, which sequesters the labile iron pool and leads to decreased PHD activity (7).”
BackgroundKeely, S., Campbell, E. L., Baird, A. W., Hansbro, P. M., Shalwitz, R. A., Kotsakis, A., McNamee, E. N., Eltzschig, H. K., Kominsky, D., & Colgan, S. P. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.29 · Cited by 110 · see citing works
Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis
Shaykhiev, R., & Bals, R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207096 · Cited by 109 · see citing works
Erapaneedi, R., Belousov, V. V., Schäfers, M. A., & Kiefer, F. (2015) · The EMBO Journal · doi:10.15252/embj.201592775 · Cited by 108 · see citing works
Yang, M., Ma, C., Liu, S., Sun, J., Shao, Q., Gao, W., Zhang, Y., Li, Z., Xie, Q., Dong, Z., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02954.x · Cited by 99 · see citing works
Kojima, H., Kobayashi, A., Sakurai, D., Kanno, Y., Hase, H., Takahashi, R., Totsuka, Y., Semenza, G. L., Sitkovsky, M. V., & Kobata, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800167 · Cited by 99 · see citing works
Beppu, K., Nakamura, K., Linehan, W. M., Rapisarda, A., & Thiele, C. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3332 · Cited by 96 · see citing works
Pencreach, E., Guérin, É., Nicolet, C., Lelong-Rebel, I. H., Voegeli, A., Oudet, P., Larsen, A. K., Gaub, M., & Guénot, D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0889 · Cited by 88 · see citing works
Kim, S., Fridlender, Z. G., Dunn, R., Kehry, M. R., Kapoor, V., Blouin, A., Kaiser, L. R., & Albelda, S. Μ. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31816d1d6a · Cited by 75 · see citing works
Zhu, G., Tang, Y., Geng, N., Zheng, M. H., Jiang, J. D., Li, L., Li, K., Lei, Z., Chen, W., Fan, Y., et al. (2014) · Neoplasia · doi:10.1593/neo.132034 · Cited by 73 · see citing works
Loss of Fibroblast HIF-1α Accelerates Tumorigenesis
Kim, J., Evans, C. E., Weidemann, A., Takeda, N., Lee, Y. S., Stockmann, C., Branco‐Price, C., Brandberg, F., Leone, G. W., Ostrowski, M. C., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0534 · Cited by 58 · see citing works
PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis
Criscimanna, A., Duan, L.-J., Rhodes, J., Fendrich, V., Wickline, E., Hartman, D., Monga, S., Lotze, M., Gittes, G., Fong, G., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0566 · Cited by 51 · see citing works
Medot-Pirenne, M., Heilman, M. J., Saxena, M., McDermott, P. E., & Mills, C. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5877 · Cited by 45 · see citing works
Activation of HIF-1α does not increase intestinal tumorigenesis
Xue, X., Ramakrishnan, S. K., & Shah, Y. M. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00112.2014 · Cited by 44 · see citing works
Self-citationWang, C., Lee, J. H., & Kim, C. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030793 · Cited by 30 · see citing works
Mitra, A. (1999) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017995 · Cited by 19 · see citing works
Cui, Y., Wang, X., & Li, X. (2015) · Future Oncology · doi:10.2217/fon.15.205 · Cited by 6 · see citing works
The 2008 Dolph Adams Award and the State of the Journal of Leukocyte Biology
Oppenheim, J. J., & Rosenberg, H. F. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908999 · Cited by 4 · see citing works
Zornhagen, K. W., Hansen, A. E., Oxboel, J., Clemmensen, A., Ali, H. H. E., Kristensen, A. T., & Kjær, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141379 · Cited by 4 · see citing works
Flagged first, then by citations
1 of the 150 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Rius J, et al. NF-kappaB links innate immu- nity to the hypoxic response through tran- scriptional regulation of HIF-1alpha. Nature. 2008;453(7196):807-811.
- Dang EV, et al. Control of T(H)17/T(reg) bal- ance by hypoxia-inducible factor 1. Cell. 2011;146(5):772-784.
Cited by
Sorted by citations
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054 · see citing works
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico‐Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,035 · see citing works
The immunology of renal cell carcinoma
Diaz-Montero, C. M., Rini, B. I., & Finke, J. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0316-3 · Cited by 439 · see citing works
Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis
Kawanishi, S., Ohnishi, S., Ma, N., Hiraku, Y., & Murata, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081808 · Cited by 289 · see citing works
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Cytlak, U., Dyer, D. P., Honeychurch, J., Williams, K. J., Travis, M. A., & Illidge, T. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00568-1 · Cited by 262 · see citing works
Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
Sørensen, B. S., & Horsman, M. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00562 · Cited by 231 · see citing works
HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron
Singhal, R., Mitta, S. R., Das, N. K., Kerk, S. A., Sajjakulnukit, P., Solanki, S., Andren, A., Kumar, R., Olive, K. P., Banerjee, R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143691 · Cited by 215 · see citing works
Self-citationHsu, Y., Hung, J., Chang, W., Jian, S., Lin, Y.-S., Pan, Y., Wu, C., & Kuo, P. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.016 · Cited by 208 · see citing works
Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
D’Ignazio, L., Batie, M., & Rocha, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020021 · Cited by 206 · see citing works
Corre, I., Paris, F., & Huot, J. (2017) · Oncotarget · doi:10.18632/oncotarget.18264 · Cited by 195 · see citing works
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
Yu, T., Tang, B., & Sun, X. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.3.489 · Cited by 192 · see citing works
The B-Side of Cancer Immunity: The Underrated Tune
Largeot, A., Pagano, G., Gonder, S., Moussay, E., & Paggetti, J. (2019) · Cells · doi:10.3390/cells8050449 · Cited by 180 · see citing works
Hypoxia and HIF Signaling: One Axis with Divergent Effects
Corrado, C., & Fontana, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165611 · Cited by 182 · see citing works
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
Hompland, T., Fjeldbo, C. S., & Lyng, H. (2021) · Cancers · doi:10.3390/cancers13030499 · Cited by 179 · see citing works
Hypoxia-inducible factors: key regulators of myeloid cells during inflammation
Lin, N., & Simon, M. C. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84426 · Cited by 170 · see citing works
Triner, D. A., Devenport, S. N., Ramakrishnan, S. K., Ma, X., Frieler, R. A., Greenson, J. K., Inohara, N., Núñez, G., Colacino, J. A., Mortensen, R. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.12.003 · Cited by 168 · see citing works
Self-citationActivation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis
Xie, C., Yagai, T., Luo, Y., Liang, X., Chen, T., Wang, Q., Sun, D., Zhao, J., Ramakrishnan, S. K., Sun, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4412 · Cited by 161 · see citing works
Self-citationYan, Y., Liu, F., Han, L., Zhao, L., Chen, J., Olopade, O. I., He, M., & Wei, M. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0925-x · Cited by 161 · see citing works
van Staalduinen, J., Baker, D., ten Dijke, P., & van Dam, H. (2018) · Oncogene · doi:10.1038/s41388-018-0378-x · Cited by 158 · see citing works
Schwartz, A. J., Goyert, J. W., Solanki, S. A., Kerk, S. A., Chen, B., Castillo, C., Hsu, P. P., Do, B. T., Singhal, R., Dame, M. K., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00406-7 · Cited by 133 · see citing works
Self-citationHIF-2α is indispensable for regulatory T cell function
Hsu, T.-S., Lin, Y.-L., Wang, Y.-A., Mo, S.-T., Chi, P.-Y., Lai, A. C.-Y., Pan, H.-Y., Chang, Y.-J., & Lai, M.-Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18731-y · Cited by 126 · see citing works
Salman, S., Meyers, D. J., Wicks, E. E., Lee, S. N., Datan, E., Thomas, A. M., Anders, N. M., Hwang, Y., Lyu, Y., Yang, Y., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156774 · Cited by 111 · see citing works
Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer
Markopoulos, G. S., Roupakia, E., Tokamani, M., Alabasi, G., Sandaltzopoulos, R., Marcu, K. B., & Kolettas, E. (2018) · Biomedicines · doi:10.3390/biomedicines6020040 · Cited by 112 · see citing works
Exosomes increased angiogenesis in papillary thyroid cancer microenvironment
Wu, F., Li, F., Lin, X., Xu, F., Cui, R., Zhong, J., Zhu, T., Shan, S., Liao, X., Yuan, L., et al. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0008 · Cited by 107 · see citing works
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis
Meškytė, E. M., Keskas, S., & Ciribilli, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207710 · Cited by 105 · see citing works
Redox Role of ROS and Inflammation in Pulmonary Diseases
Zuo, L., & Wijegunawardana, D. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-68748-9_11 · Cited by 103 · see citing works
Hypoxia in Breast Cancer—Scientific Translation to Therapeutic and Diagnostic Clinical Applications
Zhang, Y., Zhang, H., Wang, M., Schmid, T., Xin, Z., Kozhuharova, L., Yu, W.-K., Huang, Y., Cai, F., & Biskup, E. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.652266 · Cited by 100 · see citing works
Unboxing the molecular modalities of mutagens in cancer
Kumari, S., Sharma, S., Advani, D., Khosla, A., Kumar, P., & Ambasta, R. K. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16726-w · Cited by 105 · see citing works
Sabaawy, H. E., Ryan, B. M., Khiabanian, H., & Pine, S. R. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab075 · Cited by 101 · see citing works
Qi, X., Yang, M. J., Ma, L., Sauer, M. A., Avella, D. M., Kaifi, J. T., Bryan, J. N., Cheng, K., Staveley-O’Carroll, K. F., Kimchi, E. T., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001038 · Cited by 96 · see citing works
Dong, X., Liu, T., Zhi, X., Zou, J., Zhong, J., Li, T., Mo, X.-L., Zhou, W., Guo, W., Liu, X., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2725 · Cited by 95 · see citing works
Hypoxia-mediated cancer stem cell resistance and targeted therapy
Sun, X., Lv, X., Yan, Y., Zhao, Y., Ma, R., He, M., & Wei, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110623 · Cited by 91 · see citing works
Controlled oxygen delivery to power tissue regeneration
Zoneff, E., Wang, Y., Jackson, C., Smith, O., Duchi, S., Onofrillo, C., Farrugia, B., Moulton, S. E., Williams, R., Parish, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48719-x · Cited by 89 · see citing works
Wang, M., Yan, J., Cao, X., Hua, P., & Li, Z. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113775 · Cited by 83 · see citing works
Gu, H., Huang, T., Shen, Y., Liu, Y., Zhou, F., Jin, Y., Sattar, H., & Wei, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5801209 · Cited by 83 · see citing works
Semeniuk-Wojtaś, A., Lubas, A., Stec, R., Syryło, T., Niemczyk, S., & Szczylik, C. A. (2018) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2018.01.010 · Cited by 81 · see citing works
Liu, Y., Ren, H., Zhou, Y., Shang, L., Zhang, Y., Yang, F., & Shi, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1219-7 · Cited by 81 · see citing works
3D culture technologies of cancer stem cells: promising ex vivo tumor models
Zhang, C., Yang, Z., Dong, D.-L., Jang, T., Knowles, J. C., Kim, H., Jin, G., & Xuan, Y. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420933407 · Cited by 79 · see citing works
Liu, S., Zhao, H., Hu, Y., Chang, Y. Z., Mi, Y., Li, X., Tao, D., & Qin, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05111-1 · Cited by 69 · see citing works
Zhang, L., Qiang, J., Yang, X., Wang, D., Rehman, A. U., He, X., Chen, W., Sheng, D., Zhou, L., Jiang, Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201901728 · Cited by 66 · see citing works
Elastin is a key factor of tumor development in colorectal cancer
Li, J., Xu, X., Jiang, Y., Hansbro, N. G., Hansbro, P. M., Xu, J., & Liu, G. (2020) · BMC Cancer · doi:10.1186/s12885-020-6686-x · Cited by 64 · see citing works
Triner, D. A., Castillo, C., Hakim, J. B., Xue, X., Greenson, J. K., Núñez, G., Chen, G., Colacino, J. A., & Shah, Y. M. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00386-18 · Cited by 62 · see citing works
Self-citationFung, S. W., Cheung, P. F., Yip, C. W., Ng, L. W. C., Cheung, T. T., Chong, C. C. N., Lee, C. M., Lai, P. B. S., Chan, A. W. H., Tsao, G. S., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.010 · Cited by 62 · see citing works
Dey, S., Murmu, N., Mondal, T., Saha, I., Chatterjee, S., Manna, R., Haldar, S., Dash, S. K., Sarkar, T. R., & Giri, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113801 · Cited by 58 · see citing works
Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts
Hyun, D. (2020) · Cancers · doi:10.3390/cancers12071822 · Cited by 57 · see citing works
Target of obstructive sleep apnea syndrome merge lung cancer: based on big data platform
Li, L., Lü, J., Xue, W., Wang, L., Zhai, Y., Fan, Z., Wu, G., Fan, F., Li, J., Zhang, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15372 · Cited by 53 · see citing works
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
Zhang, R., Lai, L., He, J., Chen, C., You, D., Duan, W., Dong, X., Zhu, Y., Lin, L., Shen, S., et al. (2019) · Epigenetics · doi:10.1080/15592294.2019.1573066 · Cited by 50 · see citing works
Carlo, S. E. D., Raffenne, J., Varet, H., Ode, A., Granados, D. C., Stein, M., Legendre, R., Tuckermann, J. P., Bousquet, C., & Peduto, L. (2023) · Nature Immunology · doi:10.1038/s41590-023-01642-7 · Cited by 49 · see citing works
Kim, H., & Nam, J. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01551-9 · Cited by 51 · see citing works
Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review
Haibe, Y., Husseini, Z. E., Sayed, R. E., & Shamseddine, A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176176 · Cited by 45 · see citing works
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
Toss, M. S., Abidi, A., Lesche, D., Joseph, C., Mahale, S., Saunders, H., Kader, T., Miligy, I. M., Green, A. R., Gorringe, K. L., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0797-7 · Cited by 44 · see citing works
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Song, P., Zhang, J., Tan, X., Huang, Y., Xu, J., Silk, N., Zhang, D., Liu, Q., & Jiang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.586857 · Cited by 42 · see citing works
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 41 · see citing works
Hillestad, T., Hompland, T., Fjeldbo, C. S., Skingen, V. E., Salberg, U. B., Aarnes, E., Nilsen, A., Lund, K. V., Evensen, T. S., Kristensen, G. B., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0950 · Cited by 41 · see citing works
Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress
Tang, Y., Zhang, Z., Chen, Y., Qin, S., Zhou, L., Gao, W., & Shen, Z. (2022) · Antioxidants · doi:10.3390/antiox11071324 · Cited by 41 · see citing works
Therapeutic Modification of Hypoxia
Horsman, M. R., Sørensen, B. S., Busk, M., & Siemann, D. W. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.08.014 · Cited by 39 · see citing works
Hypoxia differently modulates the release of mitochondrial and nuclear DNA
Otandault, A., Abraham, J.-D., Dache, Z. A. A., Khalyfa, A., Jariel‐Encontre, I., Forné, T., Prévostel, C., Chouaı̈b, S., Gozal, D., & Thierry, A. R. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0716-y · Cited by 38 · see citing works
Meng, X., Zhu, Y., Yang, W., Zhang, J., Jin, W., Tian, R., Yang, Z., & Wang, R. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.11.010 · Cited by 36 · see citing works
Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
Coleman, M. F., Cozzo, A. J., Pfeil, A. J., Etigunta, S. K., & Hursting, S. D. (2020) · Cancers · doi:10.3390/cancers12040852 · Cited by 37 · see citing works
Durrani, I. A., Bhatti, A., & John, P. C. L. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02040-5 · Cited by 36 · see citing works
Metallic Nanoparticles for the Modulation of Tumor Microenvironment; A New Horizon
Shariatzadeh, S., Moghimi, N., Khalafi, F., Shafiee, S., Mehrabi, M., Ilkhani, S., Tosan, F., Nakhaei, P., Alizadeh, A. M., Varma, R. S., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.847433 · Cited by 36 · see citing works
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells
Gupta, N., Gaikwad, S. R., Kaushik, I., Wright, S. E., Markiewski, M. M., & Srivastava, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105150 · Cited by 35 · see citing works
Begagić, E., Bečulić, H., Džidić-Krivić, A., Vukas, S. K., Hadžić, S., Mekić–Abazović, A., Šegalo, S., Papić, E., Muchai, E., Pugonja, R., et al. (2024) · Cancers · doi:10.3390/cancers16112089 · Cited by 32 · see citing works
Wu, C., Yang, T., Liu, Y., Yi-cheng, L., Yang, Y., Liu, X., Liu, X., Ye, L., Sun, Y., Wang, X., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1596 · Cited by 32 · see citing works
HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development
Dzhalilova, D. S., & Makarova, O. V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921100011 · Cited by 33 · see citing works
Hypoxia-Induced Signaling in Gut and Liver Pathobiology
Solanki, S. A., & Shah, Y. M. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-094743 · Cited by 32 · see citing works
Self-citationRaggi, F., & Bosco, M. C. (2020) · Cancers · doi:10.3390/cancers12051337 · Cited by 30 · see citing works
Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells
Lin, P., Hsieh, H.-Y., Chu, P., & Chen, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071939 · Cited by 30 · see citing works
Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance
Kwon, Y., Kim, Y., Jung, H. S., & Jeoung, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010051 · Cited by 29 · see citing works
Li, J., Xu, P., Wu, D., Guan, M.-J., Weng, X., Lu, Y., Zeng, Y., & Chen, R. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04030-x · Cited by 28 · see citing works
Hypoxia Shapes Autophagy in LPS-Activated Dendritic Cells
Monaci, S., Aldinucci, C., Rossi, D., Giuntini, G., Filippi, I., Ulivieri, C., Marotta, G., Sozzani, S., Carraro, F., & Naldini, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573646 · Cited by 27 · see citing works
Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
Taneja, S., Vetter, S. W., & Leclerc, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158153 · Cited by 27 · see citing works
Wegge, M., Dok, R., & Nuyts, S. (2021) · Cancers · doi:10.3390/cancers13235959 · Cited by 27 · see citing works
Kim, G. D., Shin, S.-I., Sun, P., Lee, J. E., Chung, C., Kang, Y. E., Kang, D. H., & Park, J. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011636 · Cited by 27 · see citing works
Xiong, Z., Guo, M., Yu, Y., Zhang, F., Ge, M.-K., Chen, G., & Shen, S.-M. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw089 · Cited by 25 · see citing works
Suwannakul, N., Ma, N., Thanan, R., Pinlaor, S., Ungarreevittaya, P., Midorikawa, K., Hiraku, Y., Oikawa, S., Kawanishi, S., & Murata, M. (2018) · Mediators of Inflammation · doi:10.1155/2018/4867234 · Cited by 25 · see citing works
Wei, C., Liu, X., Wang, Q., Li, Q., & Xie, M. (2021) · International Journal of Endocrinology · doi:10.1155/2021/4156187 · Cited by 25 · see citing works
Li, H., Wang, J., Jin, Y., Lin, J., Gong, L., & Xu, Y. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-1812 · Cited by 24 · see citing works
Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
Zhao, Z., Zhao, D., Ji, X., Wang, Y., & Wang, B. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00691 · Cited by 24 · see citing works
Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective
Aramini, B., Masciale, V., & Haider, K. H. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i6.406 · Cited by 23 · see citing works
Penarete-Acosta, D., Stading, R. E., Emerson, L., Horn, M., Chakraborty, S., Han, A., & Jayaraman, A. (2024) · Lab on a Chip · doi:10.1039/d4lc00013g · Cited by 23 · see citing works
Ailia, M. J., Heo, J., & Yoo, S. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076495 · Cited by 22 · see citing works
Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer
Otálora-Otálora, B. A., López-Kleine, L., & Rojas, A. P. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45010029 · Cited by 20 · see citing works
Gastric Cancer Vascularization and the Contribution of Reactive Oxygen Species
Biagioni, A., Peri, S., Versienti, G., Fiorillo, C., Becatti, M., Magnelli, L., & Papucci, L. (2023) · Biomolecules · doi:10.3390/biom13060886 · Cited by 21 · see citing works
SMAD family member 3 (SMAD3) and SMAD4 repress HIF2α-dependent iron-regulatory genes
Ma, X., Das, N. K., Castillo, C., Gourani, A., Perekatt, A. O., Verzi, M. P., & Shah, Y. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005549 · Cited by 21 · see citing works
Self-citationCritical roles of miR-21 in promotions angiogenesis: friend or foe?
Saadh, M. J., Jasim, N. Y., Ahmed, M. H., Ballal, S., Kumar, A., Atteri, S., Vashishth, R., Rizaev, J. A., Alhili, A., Jawad, M. J., et al. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01600-7 · Cited by 20 · see citing works
Xiao, Z., Jin-yin, L., Yu, Q., Zhou, T., Duan, J., Yang, Z., Liu, C., & Xu, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.778294 · Cited by 20 · see citing works
Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation
Salem, D., Chelvanambi, M., Storkus, W. J., & Fecek, R. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629519 · Cited by 19 · see citing works
Tumor-related stress regulates functional plasticity of MDSCs
Mandula, J. K., & Rodrı́guez, P. C. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104312 · Cited by 18 · see citing works
Mendoza‐Reinoso, V., Schnepp, P. M., Baek, D. Y., Rubin, J. R., Schipani, E., Keller, E. T., McCauley, L. K., & Roca, H. (2022) · Cells · doi:10.3390/cells11233712 · Cited by 18 · see citing works
HIF-2α affects proliferation and apoptosis of MG-63 osteosarcoma cells through MAPK signaling
Wang, Y., Wang, X., Su, X., & Liu, T. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6243 · Cited by 18 · see citing works
Horsman, M. R., Wittenborn, T. R., Nielsen, P. S., & Elming, P. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134778 · Cited by 18 · see citing works
Yang, A., Choi, E., Park, M. S., Kim, S., Park, M., & Kim, M. (2020) · FEBS Journal · doi:10.1111/febs.15636 · Cited by 18 · see citing works
Bousquet, P. A., Meltzer, S., Sønstevold, L., Esbensen, Y., Dueland, S., Flatmark, K., Sitter, B., Bathen, T. F., Seierstad, T., Redalen, K. R., et al. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.09.010 · Cited by 18 · see citing works
Liu, A., Huang, M.-T., Xi, Y., Deng, X.-L., & Xu, K.-S. (2025) · Biomedicines · doi:10.3390/biomedicines13061422 · Cited by 16 · see citing works
Hypoxic Regulation of Neutrophils in Cancer
Triner, D. A., & Shah, Y. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174189 · Cited by 18 · see citing works
Self-citationChu, P., Wang, S.-M., Chen, P., Tang, F., & Chiang, E. I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103153 · Cited by 17 · see citing works
Zhao, D. H., Zheng, S., Wang, X., Liu, H., Zhao, K., Li, L., & Hu, Y. (2022) · Oncogene · doi:10.1038/s41388-022-02234-9 · Cited by 17 · see citing works
Inflammation and tumor microenvironment.
Niu, T., & Zhou, F. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.230231 · Cited by 16 · see citing works
Hu, J., Meng, F., Hu, X., Huang, L., Liu, H., Liu, Z., & Li, L. (2020) · Leukemia Research · doi:10.1016/j.leukres.2020.106354 · Cited by 16 · see citing works
- Authors
- Triner, D., & Shah, Y. M.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Shah, Yatrik M.
- ORCID
- Shah, Yatrik M.
- Venue
- Journal of Clinical Investigation
- Published
- 2016-08-15
- Volume
- 126
- Issue
- 10
- Pages
- 3689-3698
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5096825
- OpenAlex
- W2514692794
- Cited by
- 199
- References
- 150
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 27 · 2023: 14 · 2022: 24 · 2021: 24 · 2020: 35 · 2019: 15 · 2018: 15 · 2017: 11 · 2016: 2
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Michigan (48109)
- National Institutes of Health
- College of Pharmacy, University of Michigan
- Medical School, University of Michigan
- National Cancer Institute (R01CA148828)
- National Institute of General Medical Sciences (T32GM007863)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933, R01DK095201, T32DK094775)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- hypoxia-inducible factor, HIF-1α, HIF-2α, tumor microenvironment, tumor inflammation, antitumor immunity, tumor hypoxia, angiogenesis, reactive oxygen species, cytokine production, immune cell recruitment, tumor growth
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Humans, Inflammation, Neoplasms, Neovascularization, Pathologic, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review